5EQY
Crystal structure of choline kinase alpha-1 bound by 5-[(4-methyl-1,4-diazepan-1-yl)methyl]-2-[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]benzenecarbonitrile (compound 65)
Summary for 5EQY
Entry DOI | 10.2210/pdb5eqy/pdb |
Related | 5EQE 5EQP |
Descriptor | Choline kinase alpha, 5-[(4-methyl-1,4-diazepan-1-yl)methyl]-2-[4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]benzenecarbonitrile (3 entities in total) |
Functional Keywords | kinase, inhibitor, drug target, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Cytoplasm: P35790 |
Total number of polymer chains | 2 |
Total formula weight | 94576.19 |
Authors | Zhou, T.,Zhu, X.,Dalgarno, D.C. (deposition date: 2015-11-13, release date: 2016-01-06, Last modification date: 2023-09-27) |
Primary citation | Zech, S.G.,Kohlmann, A.,Zhou, T.,Li, F.,Squillace, R.M.,Parillon, L.E.,Greenfield, M.T.,Miller, D.P.,Qi, J.,Thomas, R.M.,Wang, Y.,Xu, Y.,Miret, J.J.,Shakespeare, W.C.,Zhu, X.,Dalgarno, D.C. Novel Small Molecule Inhibitors of Choline Kinase Identified by Fragment-Based Drug Discovery. J.Med.Chem., 59:671-686, 2016 Cited by PubMed: 26700752DOI: 10.1021/acs.jmedchem.5b01552 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.5 Å) |
Structure validation
Download full validation report